Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -11.201% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. Cc1c(Cl)cccc1Nc1nc(N)nc(CSc2ncccn2)n1
b. CC1CC(C)(C)N(C(=O)CSc2ccc(-c3ccc(F)cc3)nn2)c2ccccc21
c. COc1ccc(NC(=O)c2ccc3[nH]c(C)c(C)c3c2)cc1
Answer: a. Cc1c(Cl)cccc1Nc1nc(N)nc(CSc2ncccn2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(Cl)cccc1Nc1nc(N)nc(CSc2ncccn2)n1
Cc1c(Cl)cccc1Nc1nc(N)nc(CSc2ncccn2)n1
2-N-(3-chloro-2-methylphenyl)-6-(pyrimidin-2-ylsulfanylmethyl)-1,3,5-triazine-2,4-diamine